| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -43 | -39 |
| Net decrease in cash and cash equivalents | -8,349 | -5,118 |
| Cash and cash equivalents at beginning of period | 25,229 | - |
| Cash and cash equivalents at end of period | 16,880 | - |
Vaxart, Inc. (VXRT)
Vaxart, Inc. (VXRT)